Oxalate nephropathy precipitated by linaclotide in a high-risk patient

Linaclotide can contribute to ON in predisposed patients. Clinicians should consider medication history and risk factors in unexplained AKI and pursuing kidney biopsy for diagnosis.

Authors

Institutions

Publication Details

Journal
Clinical Nephrology - Case Studies
Published
2025-01-01
DOI
https://doi.org/10.5414/cncs111722
Citations
1
Primary Topic
Kidney Stones and Urolithiasis Treatments
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oxalate nephropathy precipitated by linaclotide in a high-risk patient

Andrea Lightle, Mauricio Monrroy, Geovani Faddoul, Omar Ali
1 citations
Clinical Nephrology - Case Studies
Kidney Stones and Urolithiasis Treatments
1.52
article

Oxalate nephropathy precipitated by linaclotide in a high-risk patient

Andrea Lightle, Mauricio Monrroy, Geovani Faddoul, Omar Ali
article en
1 citations

Abstract

Linaclotide can contribute to ON in predisposed patients. Clinicians should consider medication history and risk factors in unexplained AKI and pursuing kidney biopsy for diagnosis.

Clinical Nephrology - Case StudiesVol. 13(1)
Albany Medical Center Hospital (US)
Openalex Percentile: Top 13%
Kidney Stones and Urolithiasis Treatments
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Oxalate nephropathy precipitated by linaclotide in a high-risk patient — Andrea Lightle, Mauricio Monrroy, et al. · Clinical Nephrology - Case Studies (2025) | TGRS Research Map | TGRS